Can your CDMO tackle Host Cell Proteins? | Degrading HCPs

One of our clients outsourced their #mAb drug product to a Contract Development and Manufacturing Organization \(CDMO\).
They depended on the CDMO to ensure the purity and efficacy of their product. However, the drug showed poor stability over time, and the CDMO could not identify the cause.
🎥 Watch this video to learn how we helped our client eliminate several lipases and improve product stability - and how we can collaborate with your CDMO to keep your product timeline on track.